The 3rd Edition of the Immuno-Oncology & Biomarker Summit, organised by Veridon Global, will convene in Basel, Switzerland on 11–12 March 2027, bringing together senior leaders from pharma, biotech, diagnostics, CROs, academia and technology to advance cancer research, biomarker discovery and precision immuno-oncology. Why Basel? A Strategic Move to Europe’s Pharma Hub Following...